Loading…
Company experiences notable increase in stock price.
Biodexa Pharmaceuticals Plc (BDRX) has experienced a significant surge in its stock price. The surge occurred following the announcement of positive clinical trial results for one of its key drug candidates.
The company did not provide specific figures for the stock price increase. However, the surge was notable enough to attract attention from investors and analysts.
As of the latest available data, Biodexa Pharmaceuticals Plc has a free float of 60,827,246,000 and 619,520 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.